novo nordisk tirzepatide Nordisk's CagriSema Shows Strong Weight-Loss Results But Trails Eli Lilly's in Latest Clinical Data - News Tirzepatide gives Novo Nordisk's semaglutide

It can affect the unborn baby, so they must speak with their doctor

The dataset included nearly six times more patient-years than earlier major studies examining this question

Impact on Weight Loss While both medications offer significant weight loss benefits, studies have shown that Tirzepatide often leads to greater weight reduction than Semaglutide

Table 1 Efficacy of GLP-1 agonists efficacy (adapted from UpToDate) ( GLP-1, glucagon-like peptide 1

Opt for plain or Greek yoghurt with natural fruit instead of sugar-heavy alternatives

Despite this difference in volume, Wegovy showed the strongest disproportionality signal for ischemic optic neuropathy (reporting odds ratio [OR]=74.89) compared with Novo Nordisk diabetic drug Ozempic (reporting OR=18.81)